Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03903588 · ClinicalTrials.gov registry record
The Heidelberg Engineering SPECTRALIS Macular Precision and Agreement Study
A clinical trial, sponsored by Heidelberg Engineering.
- Completed
- Registry status
- 86
- Enrollment target
NCT03903588 is a clinical trial that has completed, run by Heidelberg Engineering. The registered enrollment target is 86 participants.
The verdict
NCT03903588 has completed, sponsored by Heidelberg Engineering.
- COMPLETED
- Registry status
- 86 participants
- Enrollment target
Study Summary
This is a prospective clinical study that will be conducted at one clinical site located in the United States to assess two grids.
Interventions
- DEVICE Optical Coherence Tomography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2019-03-22 |
| Est. Completion | 2019-09-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03903588
The ClinicalTrials.gov registry entry for NCT03903588 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Heidelberg Engineering, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Optical Coherence Tomography is the first listed.
NCT03903588 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03903588 about?
NCT03903588 is a clinical study titled "The Heidelberg Engineering SPECTRALIS Macular Precision and Agreement Study". This is a prospective clinical study that will be conducted at one clinical site located in the United States to assess two grids.
What is the current status of trial NCT03903588?
This trial is currently completed. The enrollment target is 86 participants. The study started on 2019-03-22. Estimated completion is 2019-09-12.
What interventions are being tested in trial NCT03903588?
The interventions under investigation include: Optical Coherence Tomography (DEVICE).
Who is sponsoring clinical trial NCT03903588?
This trial is sponsored by Heidelberg Engineering, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.